Primary Care

Pulmonary Vascular Disease   

Questions discussed in this category


Provoked or unprovoked VTE: Do you use D-Dimer (or even repeat imaging to reassess residual clot) in any capacity to guide anticoagulation duration? E...

The patient takes frequent flights for their job, with no prior history of VTE, and has already been taking measures for prevention including frequent...

Is there a difference in monitoring frequency for legacy drugs like bosentan vs newer agents (macitentan, ambrisentan)?

If there are a low-risk patients who can be monitored, how would you do so? If unprovoked, would you consider stopping anticoagulation?


Papers discussed in this category


AJR Am J Roentgenol,

Blood, 2020 Jan 30

Cochrane Database Syst Rev, 2021 Mar 26

Blood Adv,

CMAJ,

N Engl J Med, 2021 Jan 13

Journal of general internal medicine, 2007-01

Blood advances, 2018-11-27

Blood advances, 2023 Nov 28